A METHOD FOR ALTERING THE CD4/CD8 RATIO AND THE MONONUCLEAR CELLULAR INFILTRATE INTO A TUMOR

• 1. 改变CD4/CD8和进入肿瘤的单核细胞浸润液的方法 [P] . 中国专利： CN101005760A . 2007-07-25
• 2. 一种分离提纯小鼠肿瘤组织浸润CD4⁺CD25⁺调节性T细胞的方法 [P] . 中国专利： CN108165530B . 2021.08.27
• 3. A METHOD FOR ALTERING THE CD4/CD8 RATIO AND THE MONONUCLEAR CELLULAR INFILTRATE INTO A TUMOR [P] . 欧洲知识产权局专利： EP1753452A4 . 2009-07-22

  机译： 一种改变CD4 / CD8比例和单核细胞浸润成肿瘤的方法

• 4. Method for altering the CD4/CD8 ratio and the mononuclear cellular infiltrate into a tumor [P] . 美国专利： US2008131396A1 . 2008-06-05

  机译： 改变CD4 / CD8比例和单核细胞浸润进入肿瘤的方法

• 5. A METHOD FOR ALTERING THE CD4/CD8 RATIO AND THE MONONUCLEAR CELLULAR INFILTRATE INTO A TUMOR [P] . 欧洲知识产权局专利： EP1753452A2 . 2007-02-21

  机译： 一种改变CD4 / CD8比例和单核细胞浸润成肿瘤的方法

• 1. Selective support of a mouse thymus epithelial cell line （MTEC1） to the viability and proliferation of CD4＋CD8—,CD4—CD8—,and CD4＋CD8＋thymocytes in vitro [J] . CHENWEIFENG, JAPINGATO, 等 细胞研究：英文版 . 1992,第002期
• 2. Cone beam computed tomography-guided differences among registration methods for lung cancer and the effects of tumor position,treatment model,and tumor size on positioning errors [J] . Jiayu Du, Jie Tang, Qian Zhang, 肿瘤学与转化医学（英文） . 2021,第005期
• 3. A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix [J] . Walayat Shah, Xiaofei Yan, Li Jing, 中国免疫学杂志（英文版） . 2011,第001期
• 4. A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD41FOXP31 regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix [J] . Walayat Shah, Xiaofei Yan, Li Jing, 细胞与分子免疫学：英文版 . 2011,第001期
• 5. The CD4/CD8 ratio of tumor-infiltrating lymphocytes at the tumor-host interface has prognostic value in triple-negative breast cancer [J] . Kai Wang, Tiansheng Shen, Gene P. Siegal, Human Pathology . 2017,第期
• 6. MAINTAINING CD4/CD8 RATIO AND TH1-CTL SUBSETS OF CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS IN SERUM-FREE CULTURE CONDITIONS [C] . Hsin-Lin Lu, Pei-Ju Leng, Yu-Hua Su, Conference on advancing manufacture of cell and gene therapies . 2019
• 7. Provision of antigen-specific CD4+ T cells prevents the tolerization of CD8+ tumor-specific T cells in a mouse model of prostate cancer. [D] . Shafer-Weaver, Kimberly Ann. 2009
• 8. A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix [O] . Walayat Shah, Xiaofei Yan, Li Jing, 2011
• 9. A reversed CD4/CD8 ratio of tumor-infiltrating lymphocytes and a high percentage of CD4+FOXP3+ regulatory T cells are significantly associated with clinical outcome in squamous cell carcinoma of the cervix [O] . Walayat Shah, Xiaofei Yan, Li Jing, 2010

• 1. Protection of groundwater from migration of infiltrates from a chromic waste storage site and methods of treating these infiltrates [J] . Zygmunt Kowalski ,Adam Kozak ,Marcin Banach . 健康（英文） . 2010,第3期
• 2. Usefulness of liver infiltrating CD86-positive mononuclear cells for diagnosis of autoimmune hepatitis [J] . Kazutaka Kurokohchi ,Tsutomu Masaki ,Takashi Himoto . 世界胃肠病学杂志：英文版 . 2006,第16期
• 3. PREPARATION AND CYTOLYTIC TUMOR ACTIVITY OF OSTEOSARCOMA TUMOR INFILTRATING LYMPHOCYTES IN VITRO [J] . 沈关心 ,朱慧芬 ,张悦 . 中国癌症研究：英文版 . 1993,第4期
• 4. 米非司酮诱导流产改变小鼠子宫CD4+/CD8+及巨噬细胞的分布 [C] . GENG Mei-ying ,耿梅英 ,YUAN Fang-Zhong . 中国畜牧兽医学会动物解剖学及组织胚胎学分会第十七次学术研讨会 . 2012
• 5. miR-195与肿瘤浸润淋巴细胞CD3+CD4+CD8+在胃癌中的表达变化及临床意义 [A] . 张杰 . 2016